Lucid Diagnostics Inc Cash Flow-to-Debt Ratio
Lucid Diagnostics Inc cash flow-to-debt ratio. Lucid Diagnostics Inc (LUCD) has a Cash Flow-to-Debt Ratio of -0.40x as of June 2026, meaning its operating cash flow of $-11.30 Million could theoretically repay 0% of its total liabilities ($28.02 Million) in one year. See Lucid Diagnostics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lucid Diagnostics Inc (2018–2025)
Cash flow-to-debt ratio of Lucid Diagnostics Inc from 2018 to 2025. Historical debt coverage capacity for Lucid Diagnostics Inc across 8 annual periods. Also explore Lucid Diagnostics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Lucid Diagnostics Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Lucid Diagnostics Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Lucid Diagnostics Inc. For the full cash flow conversion analysis, see Lucid Diagnostics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.58x | $-46.48 Million | $29.51 Million | ▲ +9.6% |
| 2024 | -1.74x | $-44.14 Million | $25.32 Million | ▼ -57.1% |
| 2023 | -1.11x | $-32.82 Million | $29.58 Million | ▲ +64.6% |
| 2022 | -3.14x | $-29.68 Million | $9.46 Million | ▲ +24.4% |
| 2021 | -4.15x | $-17.67 Million | $4.26 Million | ▼ -1057.8% |
| 2020 | -0.36x | $-5.63 Million | $15.71 Million | ▲ +3.8% |
| 2019 | -0.37x | $-2.36 Million | $6.34 Million | ▼ -135.8% |
| 2018 | -0.16x | $-170.55K | $1.08 Million | — |